BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25801844)

  • 1. Palmitoylethanolamide Regulates Production of Pro-Angiogenic Mediators in a Model of β Amyloid-Induced Astrogliosis In Vitro.
    Cipriano M; Esposito G; Negro L; Capoccia E; Sarnelli G; Scuderi C; De Filippis D; Steardo L; Iuvone T
    CNS Neurol Disord Drug Targets; 2015; 14(7):828-37. PubMed ID: 25801844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide.
    Scuderi C; Esposito G; Blasio A; Valenza M; Arietti P; Steardo L; Carnuccio R; De Filippis D; Petrosino S; Iuvone T; Di Marzo V; Steardo L
    J Cell Mol Med; 2011 Dec; 15(12):2664-74. PubMed ID: 21255263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α.
    Scuderi C; Valenza M; Stecca C; Esposito G; Carratù MR; Steardo L
    J Neuroinflammation; 2012 Mar; 9():49. PubMed ID: 22405189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease.
    Beggiato S; Cassano T; Ferraro L; Tomasini MC
    Life Sci; 2020 Sep; 257():118037. PubMed ID: 32622942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease.
    Scuderi C; Stecca C; Valenza M; Ratano P; Bronzuoli MR; Bartoli S; Steardo L; Pompili E; Fumagalli L; Campolongo P; Steardo L
    Cell Death Dis; 2014 Sep; 5(9):e1419. PubMed ID: 25210802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner.
    Sarnelli G; D'Alessandro A; Iuvone T; Capoccia E; Gigli S; Pesce M; Seguella L; Nobile N; Aprea G; Maione F; de Palma GD; Cuomo R; Steardo L; Esposito G
    PLoS One; 2016; 11(5):e0156198. PubMed ID: 27219328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation.
    Paterniti I; Cordaro M; Campolo M; Siracusa R; Cornelius C; Navarra M; Cuzzocrea S; Esposito E
    CNS Neurol Disord Drug Targets; 2014; 13(9):1530-41. PubMed ID: 25106636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease.
    Esposito E; Impellizzeri D; Mazzon E; Paterniti I; Cuzzocrea S
    PLoS One; 2012; 7(8):e41880. PubMed ID: 22912680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.
    Esposito G; Capoccia E; Turco F; Palumbo I; Lu J; Steardo A; Cuomo R; Sarnelli G; Steardo L
    Gut; 2014 Aug; 63(8):1300-12. PubMed ID: 24082036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy.
    Citraro R; Russo E; Scicchitano F; van Rijn CM; Cosco D; Avagliano C; Russo R; D'Agostino G; Petrosino S; Guida F; Gatta L; van Luijtelaar G; Maione S; Di Marzo V; Calignano A; De Sarro G
    Neuropharmacology; 2013 Jun; 69():115-26. PubMed ID: 23206503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway.
    Jin W; Yang L; Yi Z; Fang H; Chen W; Hong Z; Zhang Y; Zhang G; Li L
    Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32326173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence.
    Avagliano C; Russo R; De Caro C; Cristiano C; La Rana G; Piegari G; Paciello O; Citraro R; Russo E; De Sarro G; Meli R; Mattace Raso G; Calignano A
    Pharmacol Res; 2016 Nov; 113(Pt A):276-289. PubMed ID: 27616549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α.
    Raso GM; Esposito E; Vitiello S; Iacono A; Santoro A; D'Agostino G; Sasso O; Russo R; Piazza PV; Calignano A; Meli R
    J Neuroendocrinol; 2011 Jul; 23(7):591-600. PubMed ID: 21554431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of palmitoylethanolamide on aqueous humor outflow.
    Kumar A; Qiao Z; Kumar P; Song ZH
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4416-25. PubMed ID: 22589443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease:
    Bronzuoli MR; Facchinetti R; Steardo L; Romano A; Stecca C; Passarella S; Steardo L; Cassano T; Scuderi C
    Oxid Med Cell Longev; 2018; 2018():4720532. PubMed ID: 29576849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice.
    Tomasini MC; Borelli AC; Beggiato S; Ferraro L; Cassano T; Tanganelli S; Antonelli T
    J Alzheimers Dis; 2015; 46(2):407-21. PubMed ID: 25765918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.
    Skaper SD; Facci L; Giusti P
    Mol Neurobiol; 2013 Oct; 48(2):340-52. PubMed ID: 23813098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice.
    Donvito G; Bagdas D; Toma W; Rahimpour E; Jackson A; Meade JA; AlSharari S; Kulkarni AR; Ivy Carroll F; Lichtman AH; Papke RL; Thakur GA; Imad Damaj M
    Exp Neurol; 2017 Sep; 295():194-201. PubMed ID: 28606623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats.
    Impellizzeri D; Ahmad A; Bruschetta G; Di Paola R; Crupi R; Paterniti I; Esposito E; Cuzzocrea S
    Eur J Pharmacol; 2015 Aug; 761():28-35. PubMed ID: 25934566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-α.
    Koch M; Kreutz S; Böttger C; Benz A; Maronde E; Ghadban C; Korf HW; Dehghani F
    Neurotox Res; 2011 Feb; 19(2):330-40. PubMed ID: 20221904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.